NASDAQ:EDAP EDAP TMS Q3 2025 Earnings Report $2.07 -0.10 (-4.61%) Closing price 10/10/2025 04:00 PM EasternExtended Trading$2.06 0.00 (-0.24%) As of 10/10/2025 04:36 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. ProfileEarnings HistoryForecast EDAP TMS EPS ResultsActual EPSN/AConsensus EPS -$0.25Beat/MissN/AOne Year Ago EPSN/AEDAP TMS Revenue ResultsActual RevenueN/AExpected Revenue$15.05 millionBeat/MissN/AYoY Revenue GrowthN/AEDAP TMS Announcement DetailsQuarterQ3 2025Date11/6/2025TimeBefore Market OpensConference Call DateThursday, November 6, 2025Conference Call Time8:30AM ETConference Call ResourcesEarnings HistoryCompany Profile EDAP TMS Earnings HeadlinesEDAP TMS: Focal One Robotic HIFU featured on ‘Health Uncensored with Dr. Drew’September 30, 2025 | msn.comFocal One® Prostate Cancer Awareness Month Campaign Shines Spotlight on Robotic HIFU Treatment OptionSeptember 30, 2025 | globenewswire.com2013 miner reveals his trading systemWhile everyone else is gambling on meme coins or chasing the next "100x moonshot," our members are systematically extracting profits from the $4 billion that changes hands in crypto every single day. | Crypto Swap Profits (Ad)Focal One® HIFU Receives Prestigious Innovation AwardSeptember 16, 2025 | globenewswire.comEDAP TMS Focuses on Robotic HIFU Leadership in Prostate CancerSeptember 9, 2025 | tipranks.comEDAP TMS receives HIFU reimbursement for prostate cancer in FranceSeptember 8, 2025 | msn.comSee More EDAP TMS Headlines Get Earnings Announcements in your inboxWant to stay updated on the latest earnings announcements and upcoming reports for companies like EDAP TMS? Sign up for Earnings360's daily newsletter to receive timely earnings updates on EDAP TMS and other key companies, straight to your email. Email Address About EDAP TMSEDAP TMS (NASDAQ:EDAP) SA (NASDAQ: EDAP) is a Lyon, France–based medical device company that develops and markets noninvasive therapeutic systems for urological applications. The firm’s core focus lies in high-intensity focused ultrasound (HIFU) for localized prostate tissue ablation and extracorporeal shock-wave lithotripsy for kidney stone fragmentation. Edap Tms’s Ablatherm HIFU platform delivers targeted ultrasound energy to treat prostate cancer without incisions, while its Sonolith line offers pulse-focused shock waves designed to break down urinary calculi. Since its founding in 1989, Edap Tms has pursued regulatory clearances in multiple markets, including CE marking in Europe and FDA clearance for its HIFU system in the United States. Beyond product sales, the company provides comprehensive training programs for urologists, ongoing service and maintenance support, and collaborates with clinical centers on research initiatives to refine treatment protocols and expand indications. Edap Tms serves a global customer base through a network of direct subsidiaries and independent distributors across North America, Europe, Latin America and Asia. Its devices are installed in academic hospitals, cancer treatment centers and specialized urology clinics, reflecting broad adoption of noninvasive therapies as alternatives to open or laparoscopic surgery. The company continues to invest in R&D to enhance image-guided accuracy, reduce treatment times and explore next-generation applications of focused energy in urology.View EDAP TMS ProfileRead more More Earnings Resources from MarketBeat Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles Tesla Earnings Loom: Bulls Eye $600, Bears Warn of $300Spotify Could Surge Higher—Here’s the Hidden Earnings SignalBerkshire-Backed Lennar Slides After Weak Q3 EarningsWall Street Eyes +30% Upside in Synopsys After Huge Earnings FallRH Stock Slides After Mixed Earnings and Tariff ConcernsCelsius Stock Surges After Blowout Earnings and Pepsi DealWhy DocuSign Could Be a SaaS Value Play After Q2 Earnings Upcoming Earnings Fastenal (10/13/2025)Wells Fargo & Company (10/14/2025)Citigroup (10/14/2025)Johnson & Johnson (10/14/2025)JPMorgan Chase & Co. (10/14/2025)The Goldman Sachs Group (10/14/2025)BlackRock (10/14/2025)ASML (10/15/2025)Kinder Morgan (10/15/2025)Bank of America (10/15/2025) Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
